Q32 Bio (QTTB) Prepaid Assets (2017 - 2026)
Q32 Bio (QTTB) recorded quarterly Prepaid Assets of $554000.0 in Q1 2026, down 31.86% quarter-over-quarter from $813000.0 in Q4 2025, and up 495.7% on a YoY basis from $93000.0 in Q1 2025.
Q32 Bio (QTTB) Prepaid Assets (2017 - 2026) Analysis & Trends
Q32 Bio's Prepaid Assets history runs 10 years deep, the most recent figure standing at $554000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets rose 495.7% year-over-year to $554000.0; the TTM figure through Mar 2026 stood at $554000.0 (up 495.7% YoY), while the FY2025 annual figure was $813000.0, down 79.22% from the prior year.
- Prepaid Assets was $554000.0 for Q1 2026 at Q32 Bio, down from $813000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $12.9 million in Q2 2022 to a low of $51000.0 in Q2 2024.
- Historically, Prepaid Assets has averaged $3.4 million across 5 years, with a median of $1.1 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 98.8% in 2024, then soared 1876.47% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $6.0 million in 2022, then tumbled by 92.87% to $427000.0 in 2023, then surged by 816.16% to $3.9 million in 2024, then tumbled by 79.22% to $813000.0 in 2025, then slumped by 31.86% to $554000.0 in 2026.
- The last three Prepaid Assets figures came in at $554000.0 (Q1 2026), $813000.0 (Q4 2025), and $996000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 554,000.00 |
| Dec 31, 2025 | 813,000.00 |
| Sep 30, 2025 | 996,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 3.91 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 529,000.00 |
| Dec 31, 2023 | 427,000.00 |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | 3.56 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 12.13 Mn |
| Jun 30, 2022 | 12.92 Mn |
| Mar 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | 7.13 Mn |
| Sep 30, 2021 | 4.27 Mn |
| Jun 30, 2021 | 4.64 Mn |